Pharma - HealthQuill

Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug to treat neurodegenerative disease, amyotrophic lateral sclerosis.

European regulator backs Biogen’s drug for amyotrophic lateral sclerosis

HQ Team February 24, 2024: Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug.

by HealthQuill
February 24, 2024
0 Comments

A single universal shot of antivenom for snake bites is not far away after scientists found a potent antibody to neutralise neurotoxins from four deadly species found in Africa, Asia and Australia.

Drugs Health Pharma

Toxinologists: Single universal snake antivenom jab is within range

HQ Team February 23, 2024: A single universal shot of antivenom for snake bites is not far away after scientists found a potent.

by HealthQuill
February 23, 2024
0 Comments

Scientists have developed a drug to treat malignant pleural mesothelioma, a fatal form of cancer that affects the lining of organs.

Drugs Health Pharma

Scientists discover drug to treat deadly malignant pleural mesothelioma

HQ Team February 2024: Scientists have developed a drug to treat malignant pleural mesothelioma, a fatal form of cancer that affects the lining.

by HealthQuill
February 22, 2024
0 Comments

Eating tuna may expose humans to methylmercury, a toxic chemical compound that affects the central nervous system, according to a study.

Climate Health Pharma

Toxic mercury levels remain stagnant in tuna for last 53 years: Study

HQ Team February 22, 2024: Eating tuna may expose humans to methylmercury, a toxic chemical that affects the central nervous system, and the.

by HealthQuill
February 22, 2024
0 Comments

Women stand to benefit more than men when they indulge in physical activities as it lowers the risk of premature death or fatal cardiovascular events, according to a study conducted by the US-based National Institutes of Health.

Drugs Health Pharma

Exercises help women more than men, cut risk of premature death

HQ Team February 21, 2024: Women stand to benefit more than men when they indulge in physical activities as it lowers the risk.

by HealthQuill
February 21, 2024
0 Comments

Johnson & Johnson announced that USFDA had approved a bi-weekly dose of its blood cancer therapy Tecvayli.

Drugs Health Pharma

Johnson & Johnson’s blood cancer medicine cleared for bi-weekly use

HQ Team February 21, 2024: Johnson & Johnson announced that USFDA had approved a bi-weekly dose of its blood cancer therapy Tecvayli. The regulatory.

by HealthQuill
February 21, 2024
0 Comments

A new weapon to kill superbugs may be on the horizon after Harvard researchers created a synthetic compound called cresomycin.

Drugs Health Pharma

Harvard researchers create superbug killer molecule cresomycin

HQ Team February 20, 2024: A new weapon to kill superbugs may be on the horizon after researchers at the Cambridge, Massachusetts-based Harvard.

by HealthQuill
February 20, 2024
0 Comments

US researchers have identified 275 million unreported genetic variants in a quarter of a million volunteers that may help understand genetic influences on health and diseases.

Drugs Health Pharma

US researchers spot 275m new genetic variants, may help treat diseases

HQ Team February 20, 2024: US researchers have identified 275 million unreported genetic variants in a quarter of a million volunteers that may.

by HealthQuill
February 20, 2024
0 Comments

Pfizer’s Velsipity, an oral drug to treat inflammatory bowel disease, got approval from the European Commission for patients aged 16 and above, according to a company statement.

Drugs Health Pharma

Pfizer Inc’s oral drug for ulcerative colitis gets approval from the EU

HQ Team February 20, 2024: Pfizer’s Velsipity, an oral drug to treat inflammatory bowel disease, got approval from the European Commission for patients.